Skip to content
All resources

Testing, quality and handling

Bacteriostatic Water and the 28-Day Rule: What It Actually Covers

AR

By

· 10 min read

A summary of published research, with citations. It states no amount, schedule or route, and makes no claim about what this compound does in a person. Supplied for laboratory research use only.

On this page · 6 sections
  1. Where does the 28-day rule come from?
  2. What does benzyl alcohol actually do?
  3. Is a preservative that is still measurable the same as a sterile vial?
  4. Does the 28-day rule apply to a peptide dissolved in bacteriostatic water?
  5. What would each claim actually need?
  6. Frequently asked questions

The "28-day rule" for bacteriostatic water is a pharmacy convention, not a chemical finding. Sterile-compounding standards such as USP <797> give an opened or punctured multiple-dose container a beyond-use date of 28 days, unless the manufacturer's labelling states a different period. It limits contamination risk from repeated entry into a preserved vial in a controlled setting. It does not show that the water, its benzyl alcohol, or anything dissolved in it remains stable or sterile for 28 days.

An unlabelled multi-dose glass vial with a grey stopper beside a desk calendar
Illustration: in-use dating is a question about time and access, not chemistry alone.

Most of the confusion around the rule comes from treating it as one claim when it is several. This page separates them: where the number comes from, what the preservative is for, what a preservative test can and cannot show, and why none of it carries over to a peptide solution.

Where does the 28-day rule come from?

The figure lives in practice standards for sterile preparation. USP General Chapter <797>, the United States Pharmacopeia's standard for compounding sterile preparations, assigns a multiple-dose container a beyond-use date of 28 days after it is first opened or punctured, unless the manufacturer specifies otherwise. US infection-control guidance from the Centers for Disease Control and Prevention repeats the same default, and Canadian provincial pharmacy regulators work from national model standards for sterile compounding that take a comparable approach. None of these documents is a law of chemistry; they are operating rules for clinical and pharmacy settings.

Three features of the rule are routinely lost when it is repeated online.

The clock starts at first entry, not at manufacture. An unopened vial carries the manufacturer's expiry date, which comes from that product's own stability data. The 28 days is in-use dating: it begins when the stopper is first punctured, because that is when contamination becomes possible.

The manufacturer's label wins. The phrase "unless otherwise specified by the manufacturer" is part of the rule, not a footnote. A label may state a shorter in-use period, or restrict the product to single use. The 28-day figure is a default for when the label is silent.

It applies to preserved, multiple-dose containers. A single-dose container has no preservative system designed to tolerate repeated entry and is treated very differently. "Bacteriostatic" is the word that puts a vial in the multiple-dose category at all.

A common explanation for why the number is 28, rather than 30 or 14, is that it matches the length of the pharmacopeial preservative challenge test, which follows an inoculated sample for 28 days. That alignment is real, but the standards present 28 days as a policy default rather than deriving it from any single experiment, so it is best read as a convention informed by that test, not as a measured property of any vial.

What does benzyl alcohol actually do?

Bacteriostatic water is sterile water containing an antimicrobial preservative, most commonly benzyl alcohol at around 0.9 per cent; the exact composition is on the label and can differ between products. Benzyl alcohol and phenol are the two preservatives most often used in licensed peptide and protein products, and preservative choice in those products is driven by three things: the concentration needed, antimicrobial performance, and the effect on the active ingredient (Meyer and colleagues, PMID 17722087).

The word that matters is bacteriostatic. At this concentration the preservative is meant to stop small numbers of organisms introduced by a needle from multiplying, and to reduce them over days. It is not a sterilant. It does not instantly kill what enters the vial, it is weaker against some organisms than others, and it does nothing to bacterial spores.

What benzyl alcohol doesWhat it does not do
Suppresses growth of low-level contamination introduced on entrySterilise a contaminated vial
Reduces viable organisms over a period of days, in a challenge testRemove endotoxin left by organisms it has already killed
Allows a container to be entered more than once under controlled conditionsSlow oxidation, hydrolysis, deamidation or aggregation of a dissolved peptide
Meet a defined performance test for the product it was formulated inGuarantee the same performance in a different formulation

That last row is where most misunderstanding begins. A preservative is validated in a specific formulation, and adding a peptide changes the formulation.

Is a preservative that is still measurable the same as a sterile vial?

No. These are different measurements answering different questions.

A chemical assay for benzyl alcohol tells you its concentration. It can show that the preservative has not evaporated, degraded or been absorbed into the stopper. It cannot tell you whether organisms entered the vial, because a preservative at full strength can still be overwhelmed by a large or resistant inoculum, and because it acts over days rather than instantly.

Sterility is a property of the contents, established by a sterility test or by a validated aseptic process — not inferred from the presence of an additive. And contamination is an event, not a rate: it happens on a particular entry, with a particular septum, hands and needle. Time since opening is a proxy for the number of those events, which is why in-use dating is expressed in days.

How often does it actually happen? A prevalence study in a 1,300-bed German hospital, prompted by two deaths linked to a contaminated multiple-dose container of contrast medium, cultured every opened multiple-dose vial in use on one day. One of 227 vials and one spike were contaminated, a rate of 0.9 per cent; only half the vials were marked with an opening date, and 109 held medicines with no preservative at all (Mattner and Gastmeier, PMID 14755229). The point is not the size of the number but where the risk came from: handling, labelling and storage, none of which a preservative assay measures.

Does the 28-day rule apply to a peptide dissolved in bacteriostatic water?

No — and this is the claim the rule is most often stretched to cover. Once a peptide is dissolved in bacteriostatic water, the result is a new preparation with its own chemistry. The 28-day default belongs to the diluent's container. It says nothing about the solution made from it, for four reasons.

Chemical stability runs on a separate clock. Benzyl alcohol suppresses microbes; it has no effect on the reactions that degrade a peptide in water — methionine oxidation, aspartate isomerisation, deamidation, aggregation. Those rates are set by the sequence, the pH, temperature, light and container. The general chemistry is covered in lyophilised peptides and what degrades them; two compound-specific examples are MOTS-c stability after reconstitution and BPC-157 stability after reconstitution.

The preservative is not inert towards the solute. Benzyl alcohol is known to destabilise some proteins. In interferon alfa-2a it induced aggregation in a concentration-dependent manner by populating a partially unfolded intermediate, lowering the temperature at which aggregation began (Bis and colleagues, PMID 25100180). A short peptide has far less folded structure to lose than a protein, so this finding does not transfer directly — but it is a clear demonstration that preservative and solute interact, and that compatibility is a question to be tested, not assumed.

The solute can change the preservative's performance. Antimicrobial effectiveness is formulation-dependent. A change in pH, the presence of components that bind or partition the preservative, or a different container closure can all alter how well it works. Preservative effectiveness demonstrated for the diluent alone is not demonstrated for the diluent plus a peptide.

Beyond-use dating for a compounded preparation is its own determination. Pharmacy standards treat a prepared solution separately from the multiple-dose container its diluent came from, and assign dating according to how it was made, whether it was tested, and what stability data exist for that specific preparation. Borrowing the diluent's 28 days skips every one of those steps.

This site states no beyond-use date for any peptide solution. A real one would come from a stability study of that solution, with methods able to detect each degradation route and acceptance criteria fixed in advance. Concentration arithmetic — mass over volume — is the only calculation offered here, at the concentration calculator, and it stops there.

What would each claim actually need?

ClaimEvidence it requires
"The diluent can be entered more than once"A preservative system that passes a challenge test in that formulation, plus aseptic handling
"This opened vial is still sterile"A sterility result or a validated aseptic process — not the date
"The preservative is still present"A chemical assay for benzyl alcohol
"The dissolved peptide is unchanged"A stability-indicating assay over time, with replicates and controls
"The solution has a 28-day shelf life"A stability study of that solution — which the multiple-dose vial rule is not

The way the diluent itself differs from unpreserved sterile water is set out in bacteriostatic water vs sterile water, and why acidified diluents solve a different problem in acetic acid vs bacteriostatic water. Bench technique for septum preparation, dissolution and aliquoting is in handling research peptides in the laboratory.

A final caution about the preservative itself: benzyl alcohol is a pharmacologically active substance in its own right, and its history includes the "gasping syndrome" described in 1982 in association with benzyl alcohol poisoning (Gershanik and colleagues, PMID 7133084). It is the reason licensed product labels carry population restrictions, and a reminder that "bacteriostatic" describes a function, not harmlessness.

Supplied here for laboratory use: Bacteriostatic water. The laboratory's certificate for each lot is linked from its product page. For laboratory research use only. Nothing here is medical, dosing, or therapeutic guidance.

Frequently asked questions

Does bacteriostatic water expire 28 days after I receive it? No. An unopened vial follows the expiry date printed by the manufacturer, which reflects that product's own stability data. The 28-day convention is in-use dating: it starts at the first puncture of the stopper, because that is the moment contamination becomes possible, and it applies only where the manufacturer's labelling does not specify a different period.

Is the 28-day rule a legal requirement? It is a professional standard for sterile compounding and clinical practice, enforced through pharmacy regulation in the settings it governs. A research laboratory is normally bound instead by its own institution's procedures, which often adopt the same default for preserved multiple-dose containers. Either way, the manufacturer's label takes precedence over the general rule.

Can testing the benzyl alcohol level show a vial is still good? It can show the preservative is still present at its labelled concentration, which is useful but narrow. It cannot show the contents are sterile, because contamination can occur on any entry and a preservative acts over days. Sterility and preservative concentration are separate measurements answering separate questions, and neither says anything about a dissolved peptide.

Does refrigerating an opened vial extend the 28 days? The convention does not provide for extension by storage condition, and nothing in it suggests cold storage substitutes for a time limit. Refrigeration slows microbial growth and chemical reactions, but it does not reverse contamination. Any storage instruction on the manufacturer's label applies in addition to, not instead of, in-use dating.

If a peptide is dissolved in bacteriostatic water, is the solution good for 28 days? No. The 28-day figure describes a preserved diluent container, not the preparation made from it. A peptide solution degrades on its own chemical timetable, set by its sequence, pH, temperature and container, and the preservative does nothing to slow that. Only a stability study of that specific solution could support a time limit.

Selected Research References

  1. Meyer BK, Ni A, Hu B, Shi L. Antimicrobial preservative use in parenteral products: past and present. Journal of Pharmaceutical Sciences. 2007;96(12):3155-3167. pubmed.ncbi.nlm.nih.gov/17722087
  2. Mattner F, Gastmeier P. Bacterial contamination of multiple-dose vials: a prevalence study. American Journal of Infection Control. 2004;32(1):12-16. pubmed.ncbi.nlm.nih.gov/14755229
  3. Bis RL, Singh SM, Cabello-Villegas J, Mallela KM. Role of benzyl alcohol in the unfolding and aggregation of interferon α-2a. Journal of Pharmaceutical Sciences. 2015;104(2):407-415. pubmed.ncbi.nlm.nih.gov/25100180
  4. Gershanik J, Boecler B, Ensley H, et al. The gasping syndrome and benzyl alcohol poisoning. New England Journal of Medicine. 1982;307(22):1384-1388. pubmed.ncbi.nlm.nih.gov/7133084

All products sold by NovaEvum are for research and laboratory use only. They are not intended for human or animal consumption, diagnosis, treatment, cure, or prevention of any disease.